Literature DB >> 27489270

Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.

Edita M Klimyte1, Stacy E Smith1, Pasqua Oreste2, David Lembo3, Rebecca Ellis Dutch4.   

Abstract

UNLABELLED: Human metapneumovirus (HMPV), a recently discovered paramyxovirus, infects nearly 100% of the world population and causes severe respiratory disease in infants, the elderly, and immunocompromised patients. We previously showed that HMPV binds heparan sulfate proteoglycans (HSPGs) and that HMPV binding requires only the viral fusion (F) protein. To characterize the features of this interaction critical for HMPV binding and the role of this interaction in infection in relevant models, we utilized sulfated polysaccharides, heparan sulfate mimetics, and occluding compounds. Iota-carrageenan demonstrated potent anti-HMPV activity by inhibiting binding to lung cells mediated by the F protein. Furthermore, analysis of a minilibrary of variably sulfated derivatives of Escherichia coli K5 polysaccharide mimicking the HS structure revealed that the highly O-sulfated K5 polysaccharides inhibited HMPV infection, identifying a potential feature of HS critical for HMPV binding. The peptide dendrimer SB105-A10, which binds HS, reduced binding and infection in an F-dependent manner, suggesting that occlusion of HS at the target cell surface is sufficient to prevent infection. HMPV infection was also inhibited by these compounds during apical infection of polarized airway tissues, suggesting that these interactions take place during HMPV infection in a physiologically relevant model. These results reveal key features of the interaction between HMPV and HS, supporting the hypothesis that apical HS in the airway serves as a binding factor during infection, and HS modulating compounds may serve as a platform for potential antiviral development. IMPORTANCE: Human metapneumovirus (HMPV) is a paramyxovirus that causes respiratory disease worldwide. It has been previously shown that HMPV requires binding to heparan sulfate on the surfaces of target cells for attachment and infection. In this study, we characterize the key features of this binding interaction using heparan sulfate mimetics, identify an important sulfate modification, and demonstrate that these interactions occur at the apical surface of polarized airway tissues. These findings provide insights into the initial binding step of HMPV infection that has potential for antiviral development.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27489270      PMCID: PMC5044844          DOI: 10.1128/JVI.01362-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Authors:  Tatiana Chirkova; Songbai Lin; Antonius G P Oomens; Kelsey A Gaston; Seyhan Boyoglu-Barnum; Jia Meng; Christopher C Stobart; Calvin U Cotton; Tina V Hartert; Martin L Moore; Assem G Ziady; Larry J Anderson
Journal:  J Gen Virol       Date:  2015-06-25       Impact factor: 3.891

Review 2.  Human metapneumovirus pneumonia in children: results of an Italian study and mini-review.

Authors:  Massimiliano Don; Matti Korppi; Francesca Valent; Raija Vainionpaa; Mario Canciani
Journal:  Scand J Infect Dis       Date:  2008

3.  The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans.

Authors:  Estela Escribano-Romero; Joanna Rawling; Blanca García-Barreno; José A Melero
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.

Authors:  Valeria Cagno; Manuela Donalisio; Andrea Civra; Marco Volante; Elena Veccelli; Pasqua Oreste; Marco Rusnati; David Lembo
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

5.  Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.

Authors:  Bernadette G van den Hoogen; Gerard J J van Doornum; John C Fockens; Jan J Cornelissen; Walter E P Beyer; Ronald de Groot; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Infect Dis       Date:  2003-10-27       Impact factor: 5.226

6.  Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection.

Authors:  G Lynch; L Low; S Li; A Sloane; S Adams; C Parish; B Kemp; A L Cunningham
Journal:  J Leukoc Biol       Date:  1994-09       Impact factor: 4.962

7.  Phenotypic responses of differentiated asthmatic human airway epithelial cultures to rhinovirus.

Authors:  Jianwu Bai; Steven L Smock; George R Jackson; Kenzie D MacIsaac; Yongsheng Huang; Courtney Mankus; Jonathan Oldach; Brian Roberts; Yu-Lu Ma; Joel A Klappenbach; Michael A Crackower; Stephen E Alves; Patrick J Hayden
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

8.  Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures.

Authors:  Isabella Bon; David Lembo; Marco Rusnati; Alberto Clò; Silvia Morini; Anna Miserocchi; Antonella Bugatti; Sonia Grigolon; Giuseppina Musumeci; Santo Landolfo; Maria Carla Re; Davide Gibellini
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

9.  Sulfated Escherichia coli K5 polysaccharide derivatives inhibit dengue virus infection of human microvascular endothelial cells by interacting with the viral envelope protein E domain III.

Authors:  Peter Vervaeke; Marijke Alen; Sam Noppen; Dominique Schols; Pasqua Oreste; Sandra Liekens
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

10.  Iota-Carrageenan is a potent inhibitor of rhinovirus infection.

Authors:  Andreas Grassauer; Regina Weinmuellner; Christiane Meier; Alexander Pretsch; Eva Prieschl-Grassauer; Hermann Unger
Journal:  Virol J       Date:  2008-09-26       Impact factor: 4.099

View more
  21 in total

1.  Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism.

Authors:  Valeria Cagno; Patrizia Andreozzi; Marco D'Alicarnasso; Paulo Jacob Silva; Marie Mueller; Marie Galloux; Ronan Le Goffic; Samuel T Jones; Marta Vallino; Jan Hodek; Jan Weber; Soumyo Sen; Emma-Rose Janeček; Ahmet Bekdemir; Barbara Sanavio; Chiara Martinelli; Manuela Donalisio; Marie-Anne Rameix Welti; Jean-Francois Eleouet; Yanxiao Han; Laurent Kaiser; Lela Vukovic; Caroline Tapparel; Petr Král; Silke Krol; David Lembo; Francesco Stellacci
Journal:  Nat Mater       Date:  2017-12-18       Impact factor: 43.841

2.  Human milk glycosaminoglycans inhibit cytomegalovirus and respiratory syncytial virus infectivity by impairing cell binding.

Authors:  Rachele Francese; Manuela Donalisio; Massimo Rittà; Federica Capitani; Veronica Mantovani; Francesca Maccari; Paola Tonetto; Guido E Moro; Enrico Bertino; Nicola Volpi; David Lembo
Journal:  Pediatr Res       Date:  2022-05-05       Impact factor: 3.756

3.  Computational Modeling of the Virucidal Inhibition Mechanism for Broad-Spectrum Antiviral Nanoparticles and HPV16 Capsid Segments.

Authors:  Parth Chaturvedi; Payam Kelich; Tara A Nitka; Lela Vuković
Journal:  J Phys Chem B       Date:  2021-11-30       Impact factor: 2.991

Review 4.  Antivirals targeting paramyxovirus membrane fusion.

Authors:  Erik M Contreras; Isaac Abrrey Monreal; Martin Ruvalcaba; Victoria Ortega; Hector C Aguilar
Journal:  Curr Opin Virol       Date:  2021-09-27       Impact factor: 7.090

5.  Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.

Authors:  J Tyler Kinder; Carole L Moncman; Chelsea Barrett; Hong Jin; Nicole Kallewaard; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

6.  Consensus and variations in cell line specificity among human metapneumovirus strains.

Authors:  Naganori Nao; Ko Sato; Junya Yamagishi; Maino Tahara; Yuichiro Nakatsu; Fumio Seki; Hiroshi Katoh; Aiko Ohnuma; Yuta Shirogane; Masahiro Hayashi; Tamio Suzuki; Hideaki Kikuta; Hidekazu Nishimura; Makoto Takeda
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

7.  Synthetic sulfonated derivatives of poly(allylamine hydrochloride) as inhibitors of human metapneumovirus.

Authors:  Justyna Ciejka; Paweł Botwina; Maria Nowakowska; Krzysztof Szczubiałka; Krzysztof Pyrc
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

8.  Vulnerability of primitive human placental trophoblast to Zika virus.

Authors:  Megan A Sheridan; Dinar Yunusov; Velmurugan Balaraman; Andrei P Alexenko; Shinichiro Yabe; Sergio Verjovski-Almeida; Danny J Schust; Alexander W Franz; Yoel Sadovsky; Toshihiko Ezashi; R Michael Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

9.  Effects of iota-carrageenan on ocular Chlamydia trachomatis infection in vitro and in vivo.

Authors:  Aleksandra Inic-Kanada; Elisabeth Stein; Marijana Stojanovic; Nadine Schuerer; Ehsan Ghasemian; Ana Filipovic; Emilija Marinkovic; Dejana Kosanovic; Talin Barisani-Asenbauer
Journal:  J Appl Phycol       Date:  2018-03-13       Impact factor: 3.215

10.  Heparan sulfate is an important mediator of Ebola virus infection in polarized epithelial cells.

Authors:  Manasi Tamhankar; Dawn M Gerhardt; Richard S Bennett; Nicole Murphy; Peter B Jahrling; Jean L Patterson
Journal:  Virol J       Date:  2018-08-31       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.